Suppr超能文献

基于 CRISPR/Cas9 的基因突变校正后,对小鼠胚胎中与不孕相关的突变进行各种修复。

Various repair events following CRISPR/Cas9-based mutational correction of an infertility-related mutation in mouse embryos.

机构信息

Ghent-Fertility and Stem Cell Team (G-FaST), Department for Reproductive Medicine, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium.

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, 2333 ZA, the Netherlands.

出版信息

J Assist Reprod Genet. 2024 Jun;41(6):1605-1617. doi: 10.1007/s10815-024-03095-9. Epub 2024 Apr 1.

Abstract

PURPOSE

Unpredictable genetic modifications and chromosomal aberrations following CRISPR/Cas9 administration hamper the efficacy of germline editing. Repair events triggered by double-strand DNA breaks (DSBs) besides non-homologous end joining and repair template-driven homology-directed repair have been insufficiently investigated in mouse. In this work, we are the first to investigate the precise repair mechanisms triggered by parental-specific DSB induction in mouse for paternal mutational correction in the context of an infertility-related mutation.

METHODS

We aimed to correct a paternal 22-nucleotide deletion in Plcz1, associated with lack of fertilisation in vitro, by administrating CRISPR/Cas9 components during intracytoplasmic injection of Plcz1-null sperm in wild-type oocytes combined with assisted oocyte activation. Through targeted next-generation sequencing, 77 injected embryos and 26 blastomeres from seven injected embryos were investigated. In addition, low-pass whole genome sequencing was successfully performed on 17 injected embryo samples.

RESULTS

Repair mechanisms induced by two different CRISPR/Cas9 guide RNA (gRNA) designs were investigated. In 13.73% (7/51; gRNA 1) and 19.05% (4/21; gRNA 2) of the targeted embryos, only the wild-type allele was observed, of which the majority (85.71%; 6/7) showed integrity of the targeted chromosome. Remarkably, for both designs, only in one of these embryos (1/7; gRNA 1 and 1/4; gRNA2) could repair template use be detected. This suggests that alternative repair events have occurred. Next, various genetic events within the same embryo were detected after single-cell analysis of four embryos.

CONCLUSION

Our results suggest the occurrence of mosaicism and complex repair events after CRISPR/Cas9 DSB induction where chromosomal integrity is predominantly contained.

摘要

目的

CRISPR/Cas9 给药后不可预测的基因修饰和染色体异常阻碍了种系编辑的疗效。除非同源末端连接和修复模板驱动的同源定向修复外,双链 DNA 断裂 (DSB) 引发的修复事件在小鼠中研究不足。在这项工作中,我们首次研究了在与生育力相关的突变背景下,父本突变校正时,通过父本特异性 DSB 诱导在小鼠中引发的精确修复机制。

方法

我们旨在通过在野生型卵母细胞中胞质内注射 Plcz1 缺失精子时同时进行辅助卵母细胞激活,用 CRISPR/Cas9 组件纠正与体外受精失败相关的 Plcz1 中的 22 个核苷酸缺失。通过靶向下一代测序,研究了 77 个注射胚胎和来自 7 个注射胚胎的 26 个卵裂球。此外,成功对 17 个注射胚胎样本进行了低通量全基因组测序。

结果

研究了两种不同的 CRISPR/Cas9 向导 RNA (gRNA) 设计所诱导的修复机制。在靶向胚胎的 13.73%(7/51;gRNA1)和 19.05%(4/21;gRNA2)中,仅观察到野生型等位基因,其中大多数(85.71%;6/7)显示靶向染色体完整。值得注意的是,对于两种设计,仅在这些胚胎中的一个(1/7;gRNA1 和 1/4;gRNA2)中可以检测到修复模板的使用。这表明发生了替代修复事件。接下来,在对四个胚胎进行单细胞分析后,在同一胚胎中检测到各种遗传事件。

结论

我们的结果表明,在 CRISPR/Cas9 DSB 诱导后,发生了嵌合体和复杂的修复事件,其中染色体完整性主要包含在内。

相似文献

1
Various repair events following CRISPR/Cas9-based mutational correction of an infertility-related mutation in mouse embryos.
J Assist Reprod Genet. 2024 Jun;41(6):1605-1617. doi: 10.1007/s10815-024-03095-9. Epub 2024 Apr 1.
4
Retained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos.
Mol Ther. 2023 Aug 2;31(8):2326-2341. doi: 10.1016/j.ymthe.2023.06.013. Epub 2023 Jun 27.
6
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
Nature. 2016 May 5;533(7601):125-9. doi: 10.1038/nature17664. Epub 2016 Apr 27.
8
Meiotic Cas9 expression mediates gene conversion in the male and female mouse germline.
PLoS Biol. 2021 Dec 23;19(12):e3001478. doi: 10.1371/journal.pbio.3001478. eCollection 2021 Dec.
10
Discovery and characterization of sgRNA-sequence-independent DNA cleavage from CRISPR/Cas9 in mouse embryos.
Genomics. 2024 May;116(3):110836. doi: 10.1016/j.ygeno.2024.110836. Epub 2024 Mar 25.

本文引用的文献

1
Retained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos.
Mol Ther. 2023 Aug 2;31(8):2326-2341. doi: 10.1016/j.ymthe.2023.06.013. Epub 2023 Jun 27.
2
Limitations of gene editing assessments in human preimplantation embryos.
Nat Commun. 2023 Mar 7;14(1):1219. doi: 10.1038/s41467-023-36820-6.
4
CRISPR/Cas gene editing in the human germline.
Semin Cell Dev Biol. 2022 Nov;131:93-107. doi: 10.1016/j.semcdb.2022.03.012. Epub 2022 Mar 16.
5
ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected.
CRISPR J. 2022 Feb;5(1):19-30. doi: 10.1089/crispr.2021.0120. Epub 2022 Jan 28.
7
Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing.
Nat Commun. 2021 Oct 6;12(1):5855. doi: 10.1038/s41467-021-26097-y.
8
Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.
Proc Natl Acad Sci U S A. 2021 Jun 1;118(22). doi: 10.1073/pnas.2004832117. Epub 2021 Apr 9.
9
Efficient embryonic homozygous gene conversion via RAD51-enhanced interhomolog repair.
Cell. 2021 Jun 10;184(12):3267-3280.e18. doi: 10.1016/j.cell.2021.04.035. Epub 2021 May 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验